Cyclosporine and COVID‐19: Risk or favorable?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cyclosporine and COVID‐19: Risk or favorable?

Published:2020-09-07 Issue:11 Volume:20 Page:2975-2982
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am. J. Transplant.

Author:

Poulsen Nadia Nicholine¹^ORCID,Brunn Albrecht²,Hornum Mads³⁴^ORCID,Blomberg Jensen Martin¹⁵^ORCID

Affiliation:

1. Department of Growth and Reproduction Group of Skeletal, Mineral, and Gonadal EndocrinologyRigshospitalet Copenhagen Denmark

2. Max von Pettenkofer‐InstituteLudwig‐Maximilians‐University Munich/German Center for Infection Research (DZIF) Munich Germany

3. Department of Nephrology Rigshospitalet Copenhagen Denmark

4. Department of Clinical Medicine Faculty of Health and Medical Sciences University of Copenhagen Denmark

5. Division of Bone and Mineral Research HSDM/HMS Harvard University Boston MAUSA

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.16250

Reference95 articles.

1. Remdesivir for the treatment of Covid‐19—preliminary report [published online ahead of print 2020];Beigel JH;N Engl J Med

2. HorbyP LimWS EmbersonJ et al.Effect of dexamethasone in hospitalized patients with COVID‐19: preliminary report. medRxiv. January2020:2020.06.22.20137273.https://doi.org/10.1101/2020.06.22.20137273.

3. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

4. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

5. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclosporine A-induced systemic metabolic perturbations in rats: A comprehensive metabolome analysis;Toxicology Letters;2024-05

2. Metabolic network and proteomic expression perturbed by cyclosporine A to model microbe Escherichia coli;Journal of Hazardous Materials;2024-02

3. Perspectives on Post-COVID-19 Pulmonary Fibrosis Treatment;Journal of Personalized Medicine;2023-12-29

4. Voclosporin and the Antiviral Effect Against SARS-CoV-2 in Immunocompromised Kidney Patients;Kidney International Reports;2023-12

5. Outcome of COVID-19 in Egyptian living-donor kidney transplant recipients and relation to maintenance immunosuppressive drugs: a pilot study;Scientific Reports;2023-11-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3